Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology
- PMID: 20951649
- DOI: 10.1016/j.transci.2010.09.015
Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology
Abstract
Objectives: The potential influence of automated red cell exchange (ARCE) on endothelial activation is not well established. This study was intended to assess whether ARCE influences circulating endothelial cells (CECs) in patients with sickle cell disease.
Background: Automated red cell exchange (ARCE) has been used to protect the patient from complications of sickle cell disease. However, the expected benefits vary in different patients. CECs reflect endothelial activation. We hypothesize that suppression of endothelial activation may be an important mechanism of ARCE.
Methods: The study included 20 patients with sickle cell disease who underwent 30 apheresis procedures. We used flow cytometry to directly compare pre- and post-apheresis CEC number (prior to ARCE and 5 days after ARCE) during the steady state and painful crisis. We also determined if independent variables (the level of plasma nitrite concentration, the percentage of circulating hemoglobin S, and painful crisis) significantly contributed to the CEC level.
Results: The mean CEC number decreased (P = 0.04), while progenitor CECs did not change in patients with sickle cell disease after ARCE compared with pre-ARCE values (P>0.05). Clinical factors such as the volume of replacement fluid and the citrate infusion rate did not correlate with post-apheresis CECsand progenitor CEC numbers. The independent variables were not significantly associated with CEC and progenitor CEC numbers.
Conclusions: ARCE can alter the CEC number, suggesting the possibility of suppression of endothelial activation. This may highlight the efficacy of ARCE for prevention or management of sickle cell vaso-occlusive crisis.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Automated red cell exchange procedures in patients with sickle cell disease.Transfus Apher Sci. 2007 Jun;36(3):305-12. doi: 10.1016/j.transci.2007.03.012. Epub 2007 Jun 20. Transfus Apher Sci. 2007. PMID: 17584530 Clinical Trial.
-
Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance.Br J Haematol. 2024 Oct;205(4):1257-1259. doi: 10.1111/bjh.19703. Epub 2024 Aug 11. Br J Haematol. 2024. PMID: 39128849
-
Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.Ther Apher Dial. 2007 Aug;11(4):255-61. doi: 10.1111/j.1744-9987.2007.00475.x. Ther Apher Dial. 2007. PMID: 17661830
-
Comprehensive guide to managing a chronic automated red cell exchange program in sickle cell disease.J Clin Apher. 2022 Oct;37(5):497-506. doi: 10.1002/jca.22014. Epub 2022 Sep 29. J Clin Apher. 2022. PMID: 36172983 Review.
-
Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease.J Clin Apher. 2017 Oct;32(5):342-367. doi: 10.1002/jca.21511. Epub 2016 Oct 9. J Clin Apher. 2017. PMID: 27723109
Cited by
-
Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.Transfusion. 2021 Sep;61(9):2775-2781. doi: 10.1111/trf.16551. Epub 2021 Jun 23. Transfusion. 2021. PMID: 34160085 Free PMC article. Clinical Trial.
-
Comparative efficacy in red blood cell exchange transfusions with different apheresis machines in patients with sickle cell disease.Indian J Hematol Blood Transfus. 2018 Jul;34(3):495-500. doi: 10.1007/s12288-017-0898-5. Epub 2017 Nov 7. Indian J Hematol Blood Transfus. 2018. PMID: 30127560 Free PMC article.
-
Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis.J Thromb Thrombolysis. 2014;37(2):97-101. doi: 10.1007/s11239-013-0914-z. J Thromb Thrombolysis. 2014. PMID: 23504572 Clinical Trial.
-
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.Ann Hematol. 2021 Sep;100(9):2195-2202. doi: 10.1007/s00277-021-04549-1. Epub 2021 May 25. Ann Hematol. 2021. PMID: 34032899 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical